Skip to main content

Table 1 COVID-19 adaptive platform trials represented in the trial coordination board

From: Coordination of COVID-19 platform trials in Europe

COVID-19 adaptive platform trials attending regularly

Trial name

Trial identifier

AMMURAVID

EudraCT2020-001854–23

ANTICOV

PACTR202006537901307

ACTIV-3

NCT04501978

ACTIV STRIVE

NCT05605093

DisCoVeRya

EudraCT2020-000936–23

ECRAID-Primea

EU GA 101046109

EU-SolidActa

EudraCT2021-000541–41, EUCT2022-500385–99-00

MANTICO-2

EudraCT2021-002612–31

PRINCIPLE

EudraCT2020-001209–22

PANORAMIC

EudraCT2021-005748–31

RECOVERY

EudraCT2020-001113–21

World Health Organization SOLIDARITY

EudraCT2020-001784–88

REMAP-CAPa

EudraCT2015-002340–14

MPX RESPONSEa

Cohort

VACCELERATEa

EU GA 101037867, EudraCT2021-004526–29 and EudraCT2021-004889–35

COMCOV1

EudraCT: 2020–005085-33

COMCOV2

EudraCT: 2021–001275-16

COMCOV3

EudraCT: 2021–004267-27

MonkeyVax

Cohort

  1. APT Adaptive platform trial
  2. aEuropean Union-funded COVID-19 adaptive platform trial